• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Internet delivered emotion regulation individual therapy effective as an adunct to reduce nonsuicidal self-injury

bySoroush NedaieandAlex Chan
July 19, 2023
in Chronic Disease, Pediatrics, Psychiatry
Reading Time: 2 mins read
Mental health collage: a calm young woman with her eyes closed, a sleeping dog and an open notebook with a pencil
Share on FacebookShare on TwitterShare on LinkedIn

1. Internet-delivered emotion regulation for adolescents (IERITA) used in combination with treatment as usual (TAU) produces larger reductions in nonsuicidal self-injury (NSSI) frequency and improves emotion dysregulation. 

Evidence Rating Level:1 (Excellent)

NSSI, affecting 3% to 7% of adolescents, refers to deliberate harm to one’s body without suicidal intent and is a significant risk factor for suicide attempts. There are limited empirically supported and accessible treatments for NSSI in adolescence. Emotional dysregulation has been identified as a key mechanism underlying NSSI, therefore IERITA has been proposed as a treatment for NSSI. This 3-site, single-masked, randomized superiority clinical trial aimed to investigate the effectiveness of therapist-guided IERITA as an adjunct to treatment as usual (TAU) compared to TAU alone. Therapist-guided IERITA comprised 11 modules for adolescents and 6 modules for parents delivered over 12 weeks, with a dedicated therapist providing online support via a message function. TAU typically involved supportive therapy sessions every 2 weeks with community clinicians. A total of 166 participants (mean [SD] age, 15.0 [1.2] years; 92.8% female) were recruited between November 2017 and April 2020, and were randomly allocated to receive therapist-guided IERITA plus TAU (84 participants) or TAU alone (82 participants). There was a significantly larger reduction in both self-reported and masked assessor-rated NSSI frequency in the IERITA plus TAU vs TAU only group, at both the 1-month and 3-month post-treatment mark. Furthermore, compared to the TAU only group, adolescents in IERITA plus TAU group demonstrated significantly larger improvements in self-reported emotion dysregulation (1-month posttreatment p<0.01, 3-month posttreatment p=0.01), self-reported self-destructive behaviors (p<0.001, p<0.001), and assessor-rated global functioning (p=0.02, p=0.009) at both 1-and 3-month posttreatment. Mediation analysis revealed week-to-week improvements in emotion dysregulation mediated week-to-week reductions in NSSI frequency in IERITA.  Overall, these findings support therapist-guided IERITA delivered adjunctive to TAU over 12 weeks as an effective treatment for NSSI, by targeting emotion dysregulation.

Click to read the study in JAMA Network Open

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

A concentrated exposure therapy intervention may be more effective than digital cognitive behavioural therapy in obsessive-compulsive disorder

Children with intellectual and developmental disabilities have increased risks of depression and anxiety

Tags: anxietyCBTcounsellingdepressionpsychiatryself-harm
Previous Post

Fruquintinib significantly improves survival in patients with refractory metastatic colorectal cancer

Next Post

#VisualAbstract: Cyclophosphamide-tacrolimus-mycophenolate mofetil is an effective prophylaxis against graft-versus-host disease

RelatedReports

Two Congolese women are engaged in a therapeutic conversation with a mental health professional, likely focusing on trauma care.
Chronic Disease

A concentrated exposure therapy intervention may be more effective than digital cognitive behavioural therapy in obsessive-compulsive disorder

October 30, 2026
A young boy studying at a desk with books and a contrasting image of an adult man walking outdoors, symbolizing the life course from childhood to adulthood.
Pediatrics

Children with intellectual and developmental disabilities have increased risks of depression and anxiety

October 14, 2026
A man sits pensively by a window with a depiction of a synapse illustrating neurotransmitter activity, suggesting a focus on mental health treatment mechanisms.
Artificial Intelligence

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

September 11, 2026
A funnel containing papers, a laboratory sample container, a physician working on a laptop, and a clock in the background, suggesting automation in medical workflows.
Artificial Intelligence

Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care

September 9, 2026
Next Post
#VisualAbstract: Cyclophosphamide-tacrolimus-mycophenolate mofetil is an effective prophylaxis against graft-versus-host disease

#VisualAbstract: Cyclophosphamide-tacrolimus-mycophenolate mofetil is an effective prophylaxis against graft-versus-host disease

Improved glycemic control in type 1 diabetics on very low-carbohydrate diets

Wellness Check: Nutrition

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Rapid antigen tests are most effective when used multiple times to detect SARS-CoV-2 infection

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • A concentrated exposure therapy intervention may be more effective than digital cognitive behavioural therapy in obsessive-compulsive disorder
  • Routine CT scans show steeper fat loss years before pancreatic cancer diagnosis
  • Post-hoc CHARM analysis linked CIRARA with better functional outcomes in selected patients with severe stroke
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.